表紙
市場調査レポート

Inotek Pharmaceuticals Corporation - 製品パイプラインレビュー

Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 192660
出版日 ページ情報 英文 27 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
Inotek Pharmaceuticals Corporation - 製品パイプラインレビュー Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2014
出版日: 2014年09月10日 ページ情報: 英文 27 Pages
概要

Inotek Pharmaceuticals Corporationの製品パイプライン分析】

Inotek Pharmaceuticals Corporation は、緑内障や造影剤腎症などの治療薬を開発している製薬会社です。特に眼の重大疾患に対処できる薬剤候補の開発に取り組み、医療ニーズを満たす新たな作用機序を持った分子を開発しています。

当レポートでは、Inotek Pharmaceuticals Corporationにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Inotek Pharmaceuticals Corporationの基本情報

  • Inotek Pharmaceuticals Corporationの概要
  • 主要情報
  • 企業情報

Inotek Pharmaceuticals Corporation:R&Dの概要

  • 主な治療範囲

Inotek Pharmaceuticals Corporation:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Inotek Pharmaceuticals Corporation:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Inotek Pharmaceuticals Corporation:薬剤プロファイル

  • trabodenoson
  • INO-4885
  • INO-741
  • INO-763
  • Small Molecules to Inhibit PARP

Inotek Pharmaceuticals Corporation:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Inotek Pharmaceuticals Corporation:最近のパイプライン動向

Inotek Pharmaceuticals Corporation:休止中のプロジェクト

Inotek Pharmaceuticals Corporation:開発が中止されたパイプライン製品

  • 開発が中止されたパイプライン製品のプロファイル
    • PJ-34

Inotek Pharmaceuticals Corporation:本社と子会社の所在地

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC06387CDB

Summary

Global Markets Direct's, 'Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2014', provides an overview of the Inotek Pharmaceuticals Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Inotek Pharmaceuticals Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Inotek Pharmaceuticals Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Inotek Pharmaceuticals Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Inotek Pharmaceuticals Corporation's pipeline products

Reasons to buy

  • Evaluate Inotek Pharmaceuticals Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Inotek Pharmaceuticals Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Inotek Pharmaceuticals Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Inotek Pharmaceuticals Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Inotek Pharmaceuticals Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Inotek Pharmaceuticals Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Inotek Pharmaceuticals Corporation Snapshot
  • Inotek Pharmaceuticals Corporation Overview
    • Key Information
    • Key Facts
  • Inotek Pharmaceuticals Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • Inotek Pharmaceuticals Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Inotek Pharmaceuticals Corporation - Pipeline Products Glance
    • Inotek Pharmaceuticals Corporation - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Inotek Pharmaceuticals Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Inotek Pharmaceuticals Corporation - Drug Profiles
    • trabodenoson
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • INO-4885
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • INO-741
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • INO-763
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit PARP
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Inotek Pharmaceuticals Corporation - Pipeline Analysis
    • Inotek Pharmaceuticals Corporation - Pipeline Products by Target
    • Inotek Pharmaceuticals Corporation - Pipeline Products by Route of Administration
    • Inotek Pharmaceuticals Corporation - Pipeline Products by Molecule Type
    • Inotek Pharmaceuticals Corporation - Pipeline Products by Mechanism of Action
  • Inotek Pharmaceuticals Corporation - Recent Pipeline Updates
  • Inotek Pharmaceuticals Corporation - Dormant Projects
  • Inotek Pharmaceuticals Corporation - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • PJ-34
  • Inotek Pharmaceuticals Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Inotek Pharmaceuticals Corporation, Key Information
  • Inotek Pharmaceuticals Corporation, Key Facts
  • Inotek Pharmaceuticals Corporation - Pipeline by Indication, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Stage of Development, 2014
  • Inotek Pharmaceuticals Corporation - Monotherapy Products in Pipeline, 2014
  • Inotek Pharmaceuticals Corporation - Phase II, 2014
  • Inotek Pharmaceuticals Corporation - Phase I, 2014
  • Inotek Pharmaceuticals Corporation - Preclinical, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Target, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Route of Administration, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Molecule Type, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline Products by Mechanism of Action, 2014
  • Inotek Pharmaceuticals Corporation - Recent Pipeline Updates, 2014
  • Inotek Pharmaceuticals Corporation - Dormant Developmental Projects,2014
  • Inotek Pharmaceuticals Corporation - Discontinued Pipeline Products, 2014

List of Figures

  • Inotek Pharmaceuticals Corporation - Pipeline by Top 10 Indication, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Stage of Development, 2014
  • Inotek Pharmaceuticals Corporation - Monotherapy Products in Pipeline, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Top 10 Target, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Top 10 Route of Administration, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline by Top 10 Molecule Type, 2014
  • Inotek Pharmaceuticals Corporation - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top